Zimmer Biomet Holdings (ZBH) Revenue — Quarter Ended Mar 31, 2023
Revenue increased in the reported quarter. The sequential rise was modest, while the year-over-year gain was substantial.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue increased in the reported quarter. The sequential rise was modest, while the year-over-year gain was substantial.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.8B
Revenue reported for this quarter.
Quarter-over-quarter
+0.3%
Change from the immediately preceding quarter.
Year-over-year
+10.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$7.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $1.8B | +1.0% |
| Sep 30, 2022 | $1.7B | -0.9% |
| Dec 31, 2022 | $1.8B | +2.7% |
| Mar 31, 2023 | $1.8B | +10.1% |
Revenue performance
Operating profit improved compared to the same quarter a year earlier, as expenses were relatively stable.
Quarterly comparison
Revenue was higher than both the immediately preceding quarter and the same quarter one year ago. The increase from the prior year was notably larger than the sequential change.
What to watch
The company's filing highlights its liquidity position, including cash on hand and available credit facilities.